World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
13808
World Ranking
2783
National Ranking
28

Overview

Jesper Eugen-Olsen is affiliated with Copenhagen University Hospital in Denmark. Their research primarily spans the field of Medicine, with a strong focus on several subfields including Infectious Diseases, Epidemiology, Nephrology, Cardiology and Cardiovascular Medicine, and Neurology.

The scientist's work covers a range of topics, notably COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, Sepsis Diagnosis and Treatment, Protease and Inhibitor Mechanisms, Acute Kidney Injury Research, Respiratory Support and Mechanisms, and Adipokines, Inflammation, and Metabolic Diseases.

Jesper Eugen-Olsen has frequent publication venues which include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of the American Society of Nephrology
  • Journal of Clinical Medicine
  • Critical Care
  • Scientific Reports

Their collaborative work is evident through frequent co-authors such as Evangelos J. Giamarellos-Bourboulis, Line Jee Hartmann Rasmussen, Athanasios Chalkias, Salim S. Hayek, and Jochen Reiser.

Selected recent papers authored or co-authored by Jesper Eugen-Olsen include:

  • Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial (2021, Nature Medicine)
  • Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation (2021, Frontiers in Immunology)
  • Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia (2020, Critical Care)
  • An open label trial of anakinra to prevent respiratory failure in COVID-19 (2021, eLife)
  • Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis (2021, The Lancet Rheumatology)

Best Publications

  • suPAR: the molecular crystal ball.

    Maria Thunø;Betina Macho;Jesper Eugen-Olsen

  • Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

    Evdoxia Kyriazopoulou;Garyfallia Poulakou;Haralampos Milionis;Simeon Metallidis

  • Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.

    J. Eugen‐Olsen;O. Andersen;A. Linneberg;S. Ladelund

  • Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.

    Kristian Kofoed;Ove Andersen;Gitte Kronborg;Michael Tvede

  • Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data

    J. P.A. Ioannidis;P. S. Rosenberg;J. J. Goedert;L. J. Ashton

  • Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia

    Jannik Helweg-Larsen;Thomas L Benfield;Jesper Eugen-Olsen;Jens D Lundgren

  • Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.

    Jesper Eugen-Olsen;Astrid K.N. Iversen;Peter Garred;Uffe Koppelhus

  • Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.

    Nicolai Sidenius;Cornelis F. M. Sier;Henrik Ullum;Bente Klarlund Pedersen

  • Robust Hepatitis C Genotype 3a Cell Culture Releasing Adapted Intergenotypic 3a/2a (S52/JFH1) Viruses

    Judith M. Gottwein;Troels K.H. Scheel;Anne M. Hoegh;Jacob B. Lademann

  • Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

    M. Ruhwald;T. Bodmer;C. Maier;M. Jepsen

  • Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.

    Troels K. H. Scheel;Judith M. Gottwein;Tanja B. Jensen;Jannick C. Prentoe

  • Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.

    L Andresen;V L Jørgensen;A Perner;A Hansen

  • Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation

    Line Jee Hartmann Rasmussen;Line Jee Hartmann Rasmussen;Jens Emil Vang Petersen;Jesper Eugen-Olsen

  • Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia.

    Nikoletta Rovina;Karolina Akinosoglou;Jesper Eugen-Olsen;Salim Hayek

  • The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau

    J Eugen-Olsen;Per Gustafson;N Sidenius;T K Fischer

  • The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.

    P. Wittenhagen;G. Kronborg;N. Weis;H. Nielsen

  • Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor

    Sarah J. Paulsen;Mette M. Rosenkilde;Jesper Eugen-Olsen;Thomas N. Kledal

  • An open label trial of anakinra to prevent respiratory failure in COVID-19.

    Evdoxia Kyriazopoulou;Periklis Panagopoulos;Symeon Metallidis;George N Dalekos

  • CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7.

    Morten Ruhwald;Morten Bjerregaard-Andersen;Paulo Rabna;Kristian Kofoed

  • Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score

    Stig Lyngbæk;Jacob L. Marott;Thomas Sehestedt;Tine W. Hansen

  • Development and Validation of a Multiplex Add-On Assay for Sepsis Biomarkers Using xMAP Technology

    Kristian Kofoed;Uffe Vest Schneider;Troels Scheel;Ove Andersen

  • Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis.

    Evdoxia Kyriazopoulou;Thomas Huet;Giulio Cavalli;Andrea Gori;Andrea Gori;Andrea Gori

  • A randomized trial of an early measles vaccine at 4½ months of age in Guinea-Bissau: sex-differential immunological effects.

    Kristoffer Jarlov Jensen;Mia Søndergaard;Andreas Andersen;Erliyani Sartono

Frequent Co-Authors

Thomas Benfield
Thomas Benfield Copenhagen University Hospital
Peter Aaby
Peter Aaby University of Southern Denmark
Lars S. Rasmussen
Lars S. Rasmussen University of Copenhagen
Peter Rossing
Peter Rossing University of Copenhagen
Mihai G. Netea
Mihai G. Netea Radboud University
Lars Køber
Lars Køber Copenhagen University Hospital
Evangelos J. Giamarellos-Bourboulis
Evangelos J. Giamarellos-Bourboulis National and Kapodistrian University of Athens
Peter Garred
Peter Garred University of Copenhagen
Allan Linneberg
Allan Linneberg University of Copenhagen
Jan Gerstoft
Jan Gerstoft Rigshospitalet

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can expand career opportunities in research, clinical practice, and specialized patient care. Many students begin their journey with nursing programs, which provide foundational knowledge critical for understanding immune system functions in healthcare settings.

Non-nurses looking to enter the field can consider online ABSN programs for non nurses. These accelerated programs are tailored to equip students with nursing skills quickly, bridging the gap between science and patient care in a focused timeframe.

For those seeking a faster entry into nursing roles, accelerated BSN programs for non nurses offer a streamlined path to earn a Bachelor of Science in Nursing, essential for advanced clinical practice and leadership positions in immunological healthcare.

Career advancement might also include becoming a Family Nurse Practitioner. The accelerated FNP programs allow RNs to quickly gain advanced practice credentials, enabling them to provide specialized care including immunological assessments and treatments.

For entry-level roles, obtaining an LPN license remains a viable option through some of the best easiest LPN programs to get into. These programs prepare students for fundamental nursing duties that support immunology-related healthcare teams.

Combining immunology knowledge with nursing credentials enhances employability and opens diverse career pathways in both clinical and research environments across the USA.

Best Scientists Citing Jesper Eugen-Olsen

Trending Scientists

Recently Published Articles